concept

MYELOMA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MYELOMA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

84Connections

0Hypotheses

0Analyses

29Outgoing

50Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	MYELOMA

Pathway Diagram

graph TD
    MYELOMA["MYELOMA"]
    MYELOMA -->|"target for"| Mtor["Mtor"]
    MYELOMA -->|"target for"| Apoptosis["Apoptosis"]
    MYELOMA -->|"target for"| Lymphoma["Lymphoma"]
    MYELOMA -->|"target for"| Ubiquitin_Proteasome["Ubiquitin-Proteasome"]
    MYELOMA -->|"target for"| Proteasome["Proteasome"]
    MYELOMA -->|"target for"| Mapk["Mapk"]
    MYELOMA -->|"target for"| Ras_Raf_Mek["Ras/Raf/Mek"]
    MYELOMA -->|"target for"| Drug_Resistance["Drug Resistance"]
    MYELOMA -->|"inhibits"| Autophagy["Autophagy"]
    OVERVIEW["OVERVIEW"] -->|"target for"| MYELOMA
    UBIQUITIN["UBIQUITIN"] -->|"target for"| MYELOMA
    Tumor["Tumor"] -->|"target for"| MYELOMA
    CANCER["CANCER"] -->|"inhibits"| MYELOMA
    GENES["GENES"] -->|"target for"| MYELOMA
    MTOR["MTOR"] -->|"target for"| MYELOMA
    APOPTOSIS["APOPTOSIS"] -->|"target for"| MYELOMA
    PTEN["PTEN"] -->|"target for"| MYELOMA
    ERK["ERK"] -->|"target for"| MYELOMA

Outgoing (29)

Target	Relation	Type	Str
Mtor	therapeutic_target	pathway	0.70
Apoptosis	therapeutic_target	pathway	0.70
Lymphoma	therapeutic_target	disease	0.65
Ras/Raf/Mek	therapeutic_target	pathway	0.60
Nf-Κb	associated_with	pathway	0.60
Ubiquitin-Proteasome	therapeutic_target	pathway	0.60
Proteasome	therapeutic_target	pathway	0.60
Mapk	therapeutic_target	pathway	0.60
Drug Resistance	therapeutic_target	pathway	0.60
Autophagy	inhibits	pathway	0.60
Apoptosis	inhibits	pathway	0.60
Cell Cycle	inhibits	pathway	0.60
Unfolded Protein Response	inhibits	pathway	0.60
Proteasome	expressed_in	pathway	0.60
Car-T	associated_with	pathway	0.60
Oxidative Stress	therapeutic_target	pathway	0.60
Invasion	regulates	pathway	0.60
Chemoresistance	regulates	pathway	0.60
Il-6 Signaling	therapeutic_target	pathway	0.60
Immune Response	therapeutic_target	pathway	0.60
Als	inhibits	disease	0.55
Inflammation	treats	disease	0.55
Lung Cancer	therapeutic_target	disease	0.55
Als	therapeutic_target	disease	0.55
Inflammation	associated_with	disease	0.55
Lymphoma	associated_with	disease	0.55
Myelodysplastic Syndrome	treats	disease	0.55
B CELLS	activates	concept	0.50
GENE EXPRESSION	activates	concept	0.50

Incoming (55)

Source	Relation	Type	Str
OVERVIEW	therapeutic_target	gene	0.85
APOPTOSIS	therapeutic_target	gene	0.75
GENES	therapeutic_target	gene	0.75
MTOR	therapeutic_target	gene	0.75
UBIQUITIN	therapeutic_target	gene	0.75
CANCER	inhibits	gene	0.75
Tumor	therapeutic_target	disease	0.75
PI3K	therapeutic_target	gene	0.65
RAS	therapeutic_target	gene	0.65
PIK3CA	therapeutic_target	gene	0.65
AKT	therapeutic_target	gene	0.65
Cancer	inhibits	disease	0.65
CANCER	therapeutic_target	gene	0.65
NF-ΚB	associated_with	gene	0.65
TNF	associated_with	gene	0.65
CALR	activates	gene	0.65
BCL2	regulates	gene	0.65
BCL-2	therapeutic_target	gene	0.65
AUTOPHAGY	inhibits	gene	0.65
APOPTOSIS	inhibits	gene	0.65
PROTEASOME INHIBITION	expressed_in	gene	0.65
CD4	inhibits	gene	0.65
INFLAMMATION	associated_with	gene	0.65
CYTOKINES	associated_with	gene	0.65
GATA2	associated_with	gene	0.65
PTEN	therapeutic_target	gene	0.65
ERK	therapeutic_target	gene	0.65
BRAF	inhibits	gene	0.65
PI3K	regulates	gene	0.65
IL-6	contributes_to	gene	0.65
FGFR3	therapeutic_target	gene	0.65
OXIDATIVE STRESS	therapeutic_target	gene	0.65
INFLAMMATION	treats	gene	0.65
MYC	therapeutic_target	gene	0.65
TP53	treats	gene	0.65
INFLAMMATION	therapeutic_target	gene	0.65
Rheumatoid Arthritis	contributes_to	disease	0.55
Cancer	associated_with	disease	0.55
Autoimmune	contributes_to	disease	0.55
Inflammation	therapeutic_target	disease	0.55
Breast Cancer	therapeutic_target	disease	0.55
Cancer	therapeutic_target	disease	0.55
Als	therapeutic_target	disease	0.55
Aging	therapeutic_target	disease	0.55
Tumor	inhibits	disease	0.55
Infection	associated_with	disease	0.55
Als	associated_with	disease	0.55
cancer	inhibits	disease	0.50
Drug Resistance	activates	pathway	0.50
BNIP3L	inhibits	protein	0.50

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning MYELOMA in their description or question text

No additional research found